Literature DB >> 30248199

Pharmacometric Modeling and Simulation Is Essential to Pediatric Clinical Pharmacology.

Michael Neely1, David Bayard1, Amit Desai2, Laura Kovanda2, Andrea Edginton3.   

Abstract

Pediatric clinical pharmacology now encompasses a wide range of activities, including drug pharmacokinetic and pharmacodynamic modeling and simulation, also known as pharmacometrics. Pediatric clinical pharmacologists may be physicians but are more likely to be pharmacists or PhD scientists, and pediatric clinical pharmacology today is largely a research specialty rather than a subspecialty for direct patient care. Pharmacometrics, including "top-down" population modeling and "bottom-up" physiologically based pharmacokinetic modeling, has become an indispensable tool for pharmaceutical industry scientists, government regulators, academic researchers, and even a handful of patient-oriented practitioners. This review summarizes the application of pharmacometrics within each of these domains and predicts future trends of further applications across the spectrum of pediatric clinical pharmacology from drug development to patient care.
© 2018, The American College of Clinical Pharmacology.

Entities:  

Keywords:  clinical pharmacology; modeling; pediatric; pharmacometrics; simulation; therapeutic drug monitoring

Mesh:

Year:  2018        PMID: 30248199     DOI: 10.1002/jcph.1316

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  2 in total

1.  Ontogeny of Scaling Factors for Pediatric Physiology-Based Pharmacokinetic Modeling and Simulation: Microsomal Protein Per Gram of Liver.

Authors:  J Steven Leeder; Jean C Dinh; Andrea Gaedigk; Vincent S Staggs; Bhagwat Prasad; Robin E Pearce
Journal:  Drug Metab Dispos       Date:  2021-10-22       Impact factor: 3.922

2.  Population pharmacokinetic modeling to facilitate dose selection of tapentadol in the pediatric population.

Authors:  Estelle Watson; Akash Khandelwal; Jan Freijer; John van den Anker; Claudia Lefeber; Mariëlle Eerdekens
Journal:  J Pain Res       Date:  2019-10-14       Impact factor: 3.133

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.